Search research articles
Contact Us
Filters
Showing results (341-350 of 367) with videos related to
Page
of 37
Sort By:
Genes & Cancer
|
July 23, 2011
PRKC-ζ Expression Promotes the Aggressive Phenotype of Human Prostate Cancer Cells and Is a Novel Target for Therapeutic Intervention
Sheng Yao, Alix Bee, Daniel Brewer, et al.
BJUI Compass
|
October 21, 2022
Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing
Eoin Dinneen, Gregory L Shaw, Roseann Kealy, et al.
Scientific Reports
|
July 13, 2017
Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer
Elzbieta Stankiewicz, Xueying Mao, D Chas Mangham, et al.
Breast Cancer Research : BCR
|
July 25, 2008
Visually assessed breast density, breast cancer risk and the importance of the craniocaudal view
Stephen W Duffy, Iris D Nagtegaal, Susan M Astley, et al.
Cancer Cytopathology
|
June 11, 2020
Benefit of double-reading cytology smears as a triage strategy among high-risk human papillomavirus-positive women in Mexico
Paula Ramírez-Palacios, Aiyu Chen, Yvonne N Flores, et al.
Pediatrics
|
July 17, 2016
Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials
Edson D Moreira, Stan L Block, Daron Ferris, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 30, 2019
The Parkinson's Disease Mendelian Randomization Research Portal
Alastair J Noyce, Sara Bandres-Ciga, Jonggeol Kim, et al.
BMC Cancer
|
June 20, 2020
What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)
David P French, Susan Astley, Adam R Brentnall, et al.
Papillomavirus Research (Amsterdam, Netherlands)
|
July 20, 2017
Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials
Lone K Petersen, Jaime Restrepo, Edson D Moreira, et al.
American Journal of Preventive Medicine
|
December 28, 2020
Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries
Claudia Robles, Laia Bruni, Amelia Acera, et al.
Page
of 37
Search research articles
Search
Showing results (341-350 of 367) with videos related to
Sort By:
Page
of 37
Genes & Cancer
|
July 23, 2011
PRKC-ζ Expression Promotes the Aggressive Phenotype of Human Prostate Cancer Cells and Is a Novel Target for Therapeutic Intervention
Sheng Yao, Alix Bee, Daniel Brewer, et al.
BJUI Compass
|
October 21, 2022
Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing
Eoin Dinneen, Gregory L Shaw, Roseann Kealy, et al.
Scientific Reports
|
July 13, 2017
Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer
Elzbieta Stankiewicz, Xueying Mao, D Chas Mangham, et al.
Breast Cancer Research : BCR
|
July 25, 2008
Visually assessed breast density, breast cancer risk and the importance of the craniocaudal view
Stephen W Duffy, Iris D Nagtegaal, Susan M Astley, et al.
Cancer Cytopathology
|
June 11, 2020
Benefit of double-reading cytology smears as a triage strategy among high-risk human papillomavirus-positive women in Mexico
Paula Ramírez-Palacios, Aiyu Chen, Yvonne N Flores, et al.
Pediatrics
|
July 17, 2016
Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials
Edson D Moreira, Stan L Block, Daron Ferris, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 30, 2019
The Parkinson's Disease Mendelian Randomization Research Portal
Alastair J Noyce, Sara Bandres-Ciga, Jonggeol Kim, et al.
BMC Cancer
|
June 20, 2020
What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)
David P French, Susan Astley, Adam R Brentnall, et al.
Papillomavirus Research (Amsterdam, Netherlands)
|
July 20, 2017
Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials
Lone K Petersen, Jaime Restrepo, Edson D Moreira, et al.
American Journal of Preventive Medicine
|
December 28, 2020
Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries
Claudia Robles, Laia Bruni, Amelia Acera, et al.
Page
of 37